The role of serial head-up tilt testing for the evaluation of therapeutic efficacy of neurally mediated syncope is reviewed. The evidence available suggests that guiding therapy based on serial head-up tilt response may not be appropriate, and large placebo-controlled trials should be conducted to address this issue.